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Major depressive disorder (MDD) patients (n = 66) treated with electroconvulsive therapy were 
stratified by the presence (n = 30) or absence (n = 36) of delusional symptoms (by Research Diagnostic 
Criteria) to compare their response to treatment. At discharge from hospital 83% of the MDD with 
psychosis group and 58% of the MDD without psychosis group were good responders (P = 0.03). The 
implications of this are discussed. 
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Introduction 
In an earlier study of the predictors of response 
to electroconvulsive therapy (ECT) (Pande et al., 
1988) we confirmed the suggestion (Abrams, 1982) 
that a diagnosis of major depressive disorder 
(MDD) of at least moderate severity leaves insuf- 
ficient variability in the symptom picture to allow 
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identification of clinical features predictive of a 
differential treatment response. Even delusional 
symptoms were not found in our study to be a 
predictor of response which is contrary to the 
earlier literature (Crow and Johnstone, 1986) sup- 
porting the presence of psychosis as a favorable 
predictor of ECT response. Since formalized di- 
agnostic systems have come into greater clinical 
use, two small studies (Rich et al., 1986; Solan et 
al., 1988) comparing ECT response rates between 
delusional depression and non-delusional depres- 
sion have reported no differences. Rich et al. 
studied 30 depressed patients (nine delusional and 
21 non-delusional) and found equal rates of re- 
sponse. Solan et al. reviewed 46 pharmacotherapy- 
resistant depressives who received ECT and found 
that delusionals and non-delusionals responded 
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equally well. Among the delusional depressives, 
response to ECT was affected by the type of 
delusions. Patients with nihilistic delusions did 
better than those with paranoid delusions. 
Since, at least on a phenomenologic basis, the 
distinction between delusional and non-delusional 
depression seems rather clear, we were prompted 
to re-examine the question of differential response 
to ECT in a sample larger than our previous 
study. Furthermore we examined the effect of 
electrode placement on the response to ECT in the 
two groups of subjects as well since it has been 
suggested that it is preferable to treat delusional 
MDD with bilateral ECT (Abrams, 1988) despite 
the risk of more cognitive impairment. 
Method 
The sample was drawn from the database of 
the Depression Program of the University of 
Michigan Medical Center. Diagnosis by the Re- 
search Diagnostic Criteria (RDC; Spitzer et al., 
1978) clinical ratings and ECT parameters (ma- 
chine, energy settings, seizure duration, etc.) are 
routinely collected on patients treated with ECT 
and are entered into the computerized database. 
Diagnostic data are obtained through a structured 
interview - the Schedule for Affective Disorders 
and Schizophrenia (SADS) ~ and/or by clinical 
interviews by at least two clinicians who use the 
RDC rules to reach a consensus diagnosis. This 
also includes consensus on the presence or ab- 
sence of psychotic and endogenous RDC sub- 
types. Clinical ratings consist of the Hamilton 
Rating Scale for Depression (HRSD) and the 
Global Assessment Scale (GAS) which are con- 
ducted by the primary clinicians and are, there- 
fore, not ‘blind’ to the treatment status. The De- 
pression Program periodically conducts interrater 
reliability training sessions for all clinicians to 
ensure consistency of ratings. 
The present sample is a subset of the above 
database and consisted of 66 inpatients (including 
48 subjects already reported on by Pande et al., 
1988) with a diagnosis of major depressive dis- 
order by the RDC and treated with ECT through 
the Electroconvulsive Therapy Program of the 
University of Michigan Medical Center. Only 
those patients who required at least five ECTs in a 
course of treatment were included. Thirty patients 
had psychotic symptoms by RDC and 36 did not. 
Clinical status was rated prior to commencement 
of ECT on the 17-item HRSD (Hamilton, 1960) 
and this rating was repeated within a week of 
ending ECT and at the time of discharge from the 
hospital. The Global Assessment Scale (GAS) was 
also collected before and after ECT. 
A sine wave MEDCRAFT or a pulse wave 
MECTA SR-2 machine was used to give ECT 
three times a week following patient screening 
with routine laboratory tests, spinal films, electro- 
cardiogram, and specialist consultation with 
cardiology and anesthesia. Glycopyrrolate O.lLO.2 
mg i.m. was used as premeditation when indi- 
cated. Anesthesia was induced with methohexital 
1 mg/kg body weight and muscle relaxation with 
succinylcholine 0.75 mg/kg body weight. Voltage 
and duration, electrode placement (unilateral 
d’Elia or bitemporal), and total number of treat- 
ments given were determined by the primary clini- 
cian. Generally, the settings for the MEDCRAFT 
machine were loo-160 V and 0.5-1.0 s, while for 
the MECTA the energy levels ranged between 30 
and 90 J. The machines were adjusted to achieve a 
seizure duration (monitored by the ‘cuff method’) 
of 25 s or more. Shorter seizures were followed by 
re-stimulation at a higher energy level. Total num- 
ber of treatments ranged between 5 and 17 (mean 
+ SD = 9.3 f 2.4). No formal attempt was made 
to control the end point of ECT which followed 
clinical judgements. 
Results 
The demographic and clinical variables of the 
two subgroups are shown in Table 1. The sex 
distribution was similar in the subgroups but the 
delusional MDD patients were significantly 
younger (P < 0.02) although neither the age of 
onset of the first depressive episode nor the num- 
ber of previous episodes was different between the 
groups. The delusionals had a significantly shorter 
hospital stay (P < 0.04) but this was accounted for 
by the non-delusionals having been in hospital 
longer before (P < 0.005) the start of ECT. 




SAMPLE CHARACTERISTICS AND ECT PARAMETERS 
Sex (M : F) 
As 
At first episode 
At present a 
Number of episodes 
Length of hospital stay a 
Before first ECT b 





(UL to BL) 
Number of ECTs 
Total seizure duration 
(mean f SD, s) 
MDD - MDD - non- 
delusional delusional 
(n=30) (n = 36) 
- 
8:22 11:25 
44.2* 19.9 47.Ok 18.2 
58.3* 14.9 65.9k 10.8 
2.1+ 2.7 3.1 f 2.9 
64.0f 25 80.0* 33 
15.2+ 12.9 31.4k 27.3 




8.95 2.9 9.5+ 2.1 
407.3 f 208.9 415.2+176.9 
aP<0.04; b P < 0.005. 
The mean number of ECTs and the cumulative 
seizure duration for the course of ECT did not 
differ, suggesting that both groups received equal 
amounts of treatment. Electrode placement, cate- 
gorized as bilateral (BL), unilateral (UL) and uni- 
lateral to bilateral switch (SW), did not differ 
significantly between the delusional and non-delu- 
sional groups. Number of treatments between UL 
and BL + SW did not differ (9.5 + 2.9 vs. 9.2 f 2.4, 
t = 0.49, P = NS) in the total sample. In the non- 
delusional group, the UL patients received 8.7 + 
2.1 ECTs versus 10.2 + 2.0 in the BL + SW (P -c 
0.05) but the difference was not significant when 
the two patients who received 14 ECTs (i.e., more 
than 2 standard deviations above the mean ECTs 
for the sample) were excluded from the BL + SW 
group. Similarly, in the delusional group, the UL 
patients received 10.3 -t 3.4 ECTs against 7.6 f 2.1 
in the BL + SW. This difference was significant 
(P -C 0.05) but when the UL patients who received 
over 14 ECTs were excluded, there was no statisti- 
cal difference. 
Baseline, i.e., pre-ECT, mean HRSD scores were 
similar in the groups (Table 2) but a repeated 
measures ANOVA for the mean HRSD scores pre 
ECT, post ECT and at discharge grouped by the 
delusional-non-delusional distinction showed a 
significant group by time interaction in favor of 
the delusional MDD group. Similarly the repeated 
measures ANOVA for the mean GAS scores pre 
ECT and post ECT revealed a significant group 
by time interaction. The total HRSD scores were 
used to categorize patients as responders or non- 
responders based on a total 17-item HRSD of 10 
points. Good responders (defined as an HRSD of 
10 or less) as compared to poor responders 
(HRSD 2 11) had a greater mean decrease in 
HRSD score at the post-ECT (75% vs. 44%, t = 5.5, 
P = 0.0001) as well as the discharge (78% vs. 50%, 
t = 7.5, P = 0.0001) ratings. The post-ECT rate of 
good treatment response was higher in the delu- 
sional (21/30, 70%) than the non-delusional group 
(17/36, 47%) (x2 = 3.5, G”= 1, P = 0.06). This 
significant trend became stronger at the time of 
discharge when 25/30 (83%) delusional and 21/36 
(58%) non-delusional patients were categorized as 
responders (x2 = 4.84, df= 1, P = 0.03). Since it 
was possible that the non-delusionals may have 
included an excess of non-endogenous depressives, 
we cross-categorized the endogenous and psycho- 
tic RDC subtypes. Of the delusional MDD group 
28/30 (93%) met the endogenous subtype as com- 
pared to 30/36 (83%) of the non-delusional group 
(x2 = 1.5, df= 1, NS). Thus, poorer response in 
TABLE 2 
PSYCHOSIS AND RESPONSE TO ECT 
MDD - MDD - non- 
delusional delusional 
(n = 30) (n = 36) 
HRSD (mean + SD) a 
Pre ECT 28.4+ 6.3 26.5+_ 6.0 
Post ECT 9.5f 6.1 11.1 rt 6.4 
At discharge 7.55 6.4 9.3* 5.7 
GAS (mean f SD) b 
Pre ECT 30.5* 9.9 37.4+ 12.9 
Post ECT 60.8 f 16.9 56.4 f 20.8 
Response rate (patients with HRSD 5 10) 
Post ECT ’ 21/30 (70%) 17/36 (47%) 
At discharge d 25,‘30 (83%) 21/36 (58%:) 
a Repeated measures ANOVA, F = 4.21, df = 2. P < 0.02. 
b Repeated measures ANOVA, F= 5.98, df = 1, P < 0.02. 
’ x2 = 3.5. df = 1, P = 0.06. 
d x2 = 4.84, df = 1, P = 0.03. 
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TABLE 3 
PSYCHOSIS, ELECTRODE PLACEMENT AND RESPONSE TO ECT 
MDD - delusional 
UL BL 
(n =17) (n =ll) 
SW 
(n = 2) 
MDD - non-delusional 
UL BL 
(n =18) (n =11) 
SW 
(n=7) 
Post ECT 9 11 1 6 8 3 
At discharge 





the non-delusionals could not be attributed to the 
lack of ‘endogenous’ features. 
At the post-ECT rating 23 of 31 (74%) patients 
treated with bilateral ECT or switched from uni- 
lateral to bilateral ECT were responders as com- 
pared to 15 of 35 (43%) treated with unilateral 
ECT (x2 = 6.61, df = 1, P = 0.01). The difference 
was not as significant at the time of discharge 
when 25/31 (81%) bilaterals and switched were 
responders as compared to 21/35 (60%) uni- 
laterals. Table 3 shows the rates of response in the 
delusional and non-delusional groups stratified by 
the electrode placement. Although delusionals re- 
ceiving bilateral ECT were more likely to be re- 
sponders the differences were not statistically sig- 
nificant. 
Discussion 
This study found that in depressed inpatients 
with a comparable severity of illness prior to treat- 
ment, there was a significant trend toward the 
delusional depressives having a higher rate of re- 
sponse than non-delusional depressives with ECT 
at the end of treatment. This difference became 
statistically significant at the time of discharge. It 
has been suggested that bilateral ECT may be 
preferable in delusional MDD (Abrams, 1988) 
hence we examined whether electrode placement 
affected response. The frequency with which uni- 
lateral and bilateral electrode placement was used 
in the delusional and non-delusional groups was 
similar. Overall, bilateral ECT was significantly 
more likely to be associated with a response at the 
end of ECT than unilateral ECT. This difference 
was not significant at discharge and may indicate 
that the electrode placement influences the speed 
of response. All of the delusional depressives 
treated with bilateral ECT were responders at the 
end of treatment and at discharge whereas among 
those treated with unilateral ECT only half were 
responders post ECT and about three-quarters at 
discharge. These differences failed to reach statis- 
tical significance. In the non-delusional patients as 
well treatment response was better in those receiv- 
ing bilateral ECT but the difference was not as 
great as in the delusional MDD patients. The 
efficacy of bilateral ECT was not significantly 
different between the delusional and non-delu- 
sional groups, nor was the efficacy of unilateral 
ECT different between the groups. 
The demographic and treatment response dif- 
ferences between the delusional and non-delu- 
sional depressives suggest that they may represent 
overlapping but distinct populations, which arrive 
at ECT for different reasons. As there were no 
significant differences in the pretreatment severity 
of depression, it is possible that delusional depres- 
sion may not be just a more severe form of depres- 
sive illness on a continuum with non-delusional 
depression. This possibility deserves further study. 
The clinical selection process as a source of bias 
also needs to be considered in that while the 
delusional depressives may receive ECT as a treat- 
ment of first choice, the non-delusional depres- 
sives often arrive at ECT after having failed to 
respond to pharmacotherapy. This would account 
for the longer hospital stay and may mean that 
this group represents a more chronic or treatment- 
refractory form of depressive illness. We could not 
analyze our sample to identify how many may 
have been referred for refractory depression as 
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opposed to those who received ECT because they 
were severely ill. We believe such analysis in fu- 
ture prospective studies would be valuable. 
Despite the retrospective nature of this study, 
the findings provide further encouragement to 
conduct prospective studies using random assign- 
ment of delusional and non-delusional depressives 
to unilateral and bilateral ECT so as to elucidate 
the role of delusional symptoms and electrode 
placement in the response to ECT. 
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